SCHEMBL29979635

SCHEMBL29979635

O=C(NC(c1ccccc1Cl)C(F)(F)F)c1cn(-c2c(F)cc(F)cc2F)c2nc(N3C[C@@H](O)[C@H](O)C3)c(F)cc2c1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHA2 P29317 1/20 0.44
FLT4 P35916 1/20 0.44
GSK3B P49841 1/20 0.44
RARB P10826 1/20 0.44
TBXAS1 P24557 1/20 0.44
SLC6A3 Q01959 1/20 0.44
LMNA P02545 3/20 0.43
KDM4E B2RXH2 3/20 0.43
ALDH1A1 P00352 2/20 0.43
POLB P06746 1/20 0.43
HPGD P15428 1/20 0.43
XBP1 P17861 1/20 0.43
NFKB1 P19838 1/20 0.43
HTT P42858 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
HSD17B10 Q99714 1/20 0.43
KMT2A Q03164 2/20 0.41
SLC22A2 O15244 3/20 0.40
DPP4 P27487 5/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19971422 1.00 EPHA2 (0.44) EPHA2FLT4GSK3BRARBTBXAS1
SCHEMBL18313454 0.90 SLC22A2 (0.40) EPHA2FLT4GSK3BRARBTBXAS1
SCHEMBL19986942 0.85 EPHA2 (0.47) EPHA2FLT4GSK3BRARBTBXAS1
SCHEMBL29980049 0.85 EPHA2 (0.47) EPHA2FLT4GSK3BRARBTBXAS1
SCHEMBL21292591 0.84 LMNA (0.46) EPHA2FLT4GSK3BRARBTBXAS1
SCHEMBL19987032 0.84 LMNA (0.46) EPHA2FLT4GSK3BRARBTBXAS1
SCHEMBL21292590 0.84 LMNA (0.46) EPHA2FLT4GSK3BRARBTBXAS1
SCHEMBL21292601 0.83 LMNA (0.43) EPHA2FLT4GSK3BRARBTBXAS1
SCHEMBL19987095 0.83 LMNA (0.43) EPHA2FLT4GSK3BRARBTBXAS1
SCHEMBL19987149 0.83 LMNA (0.43) EPHA2FLT4GSK3BRARBTBXAS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109689656-B 7-substituted 1-arylnaphthyridine-3-carboxamides and their use 拜耳股份公司 2022-10-04 CN disclosed